Global Oncology Clinical Trial Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Prostate Cancer
  • 1.2.3 Lung Cancer
  • 1.2.4 Breast Cancer
  • 1.2.5 Leukemia
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Oncology Clinical Trial Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Lab
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Clinical Trial Market Perspective (2016-2027)
• 2.2 Oncology Clinical Trial Growth Trends by Regions
  • 2.2.1 Oncology Clinical Trial Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Oncology Clinical Trial Historic Market Share by Regions (2016-2021)
  • 2.2.3 Oncology Clinical Trial Forecasted Market Size by Regions (2022-2027)
• 2.3 Oncology Clinical Trial Industry Dynamic
  • 2.3.1 Oncology Clinical Trial Market Trends
  • 2.3.2 Oncology Clinical Trial Market Drivers
  • 2.3.3 Oncology Clinical Trial Market Challenges
  • 2.3.4 Oncology Clinical Trial Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Clinical Trial Players by Revenue
  • 3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2016-2021)
  • 3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2016-2021)
• 3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
• 3.4 Global Oncology Clinical Trial Market Concentration Ratio
  • 3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2020
• 3.5 Oncology Clinical Trial Key Players Head office and Area Served
• 3.6 Key Players Oncology Clinical Trial Product Solution and Service
• 3.7 Date of Enter into Oncology Clinical Trial Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Clinical Trial Breakdown Data by Type

• 4.1 Global Oncology Clinical Trial Historic Market Size by Type (2016-2021)
• 4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2022-2027)

5 Oncology Clinical Trial Breakdown Data by Application

• 5.1 Global Oncology Clinical Trial Historic Market Size by Application (2016-2021)
• 5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Oncology Clinical Trial Market Size (2016-2027)
• 6.2 North America Oncology Clinical Trial Market Size by Type
  • 6.2.1 North America Oncology Clinical Trial Market Size by Type (2016-2021)
  • 6.2.2 North America Oncology Clinical Trial Market Size by Type (2022-2027)
  • 6.2.3 North America Oncology Clinical Trial Market Size by Type (2016-2027)
• 6.3 North America Oncology Clinical Trial Market Size by Application
  • 6.3.1 North America Oncology Clinical Trial Market Size by Application (2016-2021)
  • 6.3.2 North America Oncology Clinical Trial Market Size by Application (2022-2027)
  • 6.3.3 North America Oncology Clinical Trial Market Size by Application (2016-2027)
• 6.4 North America Oncology Clinical Trial Market Size by Country
  • 6.4.1 North America Oncology Clinical Trial Market Size by Country (2016-2021)
  • 6.4.2 North America Oncology Clinical Trial Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Oncology Clinical Trial Market Size (2016-2027)
• 7.2 Europe Oncology Clinical Trial Market Size by Type
  • 7.2.1 Europe Oncology Clinical Trial Market Size by Type (2016-2021)
  • 7.2.2 Europe Oncology Clinical Trial Market Size by Type (2022-2027)
  • 7.2.3 Europe Oncology Clinical Trial Market Size by Type (2016-2027)
• 7.3 Europe Oncology Clinical Trial Market Size by Application
  • 7.3.1 Europe Oncology Clinical Trial Market Size by Application (2016-2021)
  • 7.3.2 Europe Oncology Clinical Trial Market Size by Application (2022-2027)
  • 7.3.3 Europe Oncology Clinical Trial Market Size by Application (2016-2027)
• 7.4 Europe Oncology Clinical Trial Market Size by Country
  • 7.4.1 Europe Oncology Clinical Trial Market Size by Country (2016-2021)
  • 7.4.2 Europe Oncology Clinical Trial Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology Clinical Trial Market Size (2016-2027)
• 8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
  • 8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
  • 8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
  • 8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oncology Clinical Trial Market Size (2016-2027)
• 9.2 Latin America Oncology Clinical Trial Market Size by Type
  • 9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2016-2021)
  • 9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2022-2027)
  • 9.2.3 Latin America Oncology Clinical Trial Market Size by Type (2016-2027)
• 9.3 Latin America Oncology Clinical Trial Market Size by Application
  • 9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2016-2021)
  • 9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2022-2027)
  • 9.3.3 Latin America Oncology Clinical Trial Market Size by Application (2016-2027)
• 9.4 Latin America Oncology Clinical Trial Market Size by Country
  • 9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2016-2021)
  • 9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology Clinical Trial Market Size (2016-2027)
• 10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
  • 10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
  • 10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
  • 10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 IQVIA
  • 11.1.1 IQVIA Company Details
  • 11.1.2 IQVIA Business Overview
  • 11.1.3 IQVIA Oncology Clinical Trial Introduction
  • 11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.1.5 IQVIA Recent Development
• 11.2 Charles River Laboratory
  • 11.2.1 Charles River Laboratory Company Details
  • 11.2.2 Charles River Laboratory Business Overview
  • 11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
  • 11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.2.5 Charles River Laboratory Recent Development
• 11.3 ICON Plc
  • 11.3.1 ICON Plc Company Details
  • 11.3.2 ICON Plc Business Overview
  • 11.3.3 ICON Plc Oncology Clinical Trial Introduction
  • 11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.3.5 ICON Plc Recent Development
• 11.4 Medelis, Inc.
  • 11.4.1 Medelis, Inc. Company Details
  • 11.4.2 Medelis, Inc. Business Overview
  • 11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
  • 11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.4.5 Medelis, Inc. Recent Development
• 11.5 Medpace Holdings, Inc.
  • 11.5.1 Medpace Holdings, Inc. Company Details
  • 11.5.2 Medpace Holdings, Inc. Business Overview
  • 11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
  • 11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.5.5 Medpace Holdings, Inc. Recent Development
• 11.6 PAREXEL International
  • 11.6.1 PAREXEL International Company Details
  • 11.6.2 PAREXEL International Business Overview
  • 11.6.3 PAREXEL International Oncology Clinical Trial Introduction
  • 11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.6.5 PAREXEL International Recent Development
• 11.7 Pharmaceutical Product Development, LLC
  • 11.7.1 Pharmaceutical Product Development, LLC Company Details
  • 11.7.2 Pharmaceutical Product Development, LLC Business Overview
  • 11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
  • 11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.7.5 Pharmaceutical Product Development, LLC Recent Development
• 11.8 Pivotal
  • 11.8.1 Pivotal Company Details
  • 11.8.2 Pivotal Business Overview
  • 11.8.3 Pivotal Oncology Clinical Trial Introduction
  • 11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.8.5 Pivotal Recent Development
• 11.9 PRA Health Sciences
  • 11.9.1 PRA Health Sciences Company Details
  • 11.9.2 PRA Health Sciences Business Overview
  • 11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
  • 11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.9.5 PRA Health Sciences Recent Development
• 11.10 Syneos Health
  • 11.10.1 Syneos Health Company Details
  • 11.10.2 Syneos Health Business Overview
  • 11.10.3 Syneos Health Oncology Clinical Trial Introduction
  • 11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2016-2021)
  • 11.10.5 Syneos Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer